<!DOCTYPE html><!--8nmnW_8LUcQxaBO0rEWXk--><html lang="en" class="light"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1"/><link rel="preload" href="/rigidbodydynamicsai/_next/static/media/01d67e7cc17e7674-s.p.5b396bc1.woff2" as="font" crossorigin="" type="font/woff2"/><link rel="preload" href="/rigidbodydynamicsai/_next/static/media/2a65768255d6b625-s.p.d19752fb.woff2" as="font" crossorigin="" type="font/woff2"/><link rel="preload" href="/rigidbodydynamicsai/_next/static/media/797e433ab948586e-s.p.dbea232f.woff2" as="font" crossorigin="" type="font/woff2"/><link rel="preload" href="/rigidbodydynamicsai/_next/static/media/caa3a2e1cccd8315-s.p.853070df.woff2" as="font" crossorigin="" type="font/woff2"/><link rel="preload" as="image" href="/rigidbodydynamicsai/logo.png"/><link rel="stylesheet" href="/rigidbodydynamicsai/_next/static/chunks/43c443004b697646.css" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" href="/rigidbodydynamicsai/_next/static/chunks/e9bfe6dd4a921662.js"/><script src="/rigidbodydynamicsai/_next/static/chunks/82abf2d65f5428ae.js" async=""></script><script src="/rigidbodydynamicsai/_next/static/chunks/3d3accb022ab1997.js" async=""></script><script src="/rigidbodydynamicsai/_next/static/chunks/30fdfd80804f7e97.js" async=""></script><script src="/rigidbodydynamicsai/_next/static/chunks/turbopack-60afc366df366ef9.js" async=""></script><script src="/rigidbodydynamicsai/_next/static/chunks/8461251ea68c7ff3.js" async=""></script><script src="/rigidbodydynamicsai/_next/static/chunks/ff1a16fafef87110.js" async=""></script><script src="/rigidbodydynamicsai/_next/static/chunks/d2be314c3ece3fbe.js" async=""></script><meta name="next-size-adjust" content=""/><title>Insurance Claim Denial Management — AI Market Opportunity Research</title><meta name="description" content="15–25% of hospital claims are denied; $262B initially denied and $38–65B ultimately lost yearly. Denial management costs hospitals ~$19.7B; RCM market is $155–165B."/><meta property="og:title" content="Rigid Body Dynamics AI — AI That Does the Work for You"/><meta property="og:description" content="We research what&#x27;s next in AI and make it accessible — one problem at a time."/><meta name="twitter:card" content="summary"/><meta name="twitter:title" content="Rigid Body Dynamics AI — AI That Does the Work for You"/><meta name="twitter:description" content="We research what&#x27;s next in AI and make it accessible — one problem at a time."/><link rel="icon" href="/rigidbodydynamicsai/favicon.ico?favicon.0b3bf435.ico" sizes="256x256" type="image/x-icon"/><link rel="icon" href="/icon?64afa28a3da3d704" type="image/png" sizes="32x32"/><script src="/rigidbodydynamicsai/_next/static/chunks/a6dad97d9634a72d.js" noModule=""></script></head><body class="geist_a71539c9-module__T19VSG__variable geist_mono_8d43a2aa-module__8Li5zG__variable playfair_display_44985fd-module__vl415q__variable pixelify_sans_8b7fe3b4-module__eZKBvW__variable antialiased font-sans bg-background text-foreground"><div hidden=""><!--$--><!--/$--></div><a href="#main" class="sr-only focus-visible:not-sr-only focus-visible:absolute focus-visible:left-4 focus-visible:top-4 focus-visible:z-50 focus-visible:rounded focus-visible:bg-accent focus-visible:px-4 focus-visible:py-2 focus-visible:text-accent-foreground">Skip to main content</a><header class="fixed top-2 left-0 right-0 z-50 flex justify-center px-2 sm:top-4 sm:px-4"><div class="flex w-full items-center gap-2 rounded-xl bg-white/10 px-3 py-3 shadow-lg backdrop-blur-sm ring-1 ring-inset ring-white/20 sm:w-auto sm:py-2" style="box-shadow:0 8px 32px rgba(0,0,0,0.18), inset 0 1px 0 rgba(255,255,255,0.25)"><a class="mr-1 flex items-center justify-center rounded-md p-1 transition-opacity hover:opacity-80 focus-visible:outline focus-visible:outline-2 focus-visible:outline-foreground focus-visible:outline-offset-2" aria-label="Rigid Body Dynamics AI home" href="/rigidbodydynamicsai"><img alt="" width="28" height="28" decoding="async" data-nimg="1" class="h-7 w-7 object-contain" style="color:transparent" src="/rigidbodydynamicsai/logo.png"/></a><nav aria-label="Main navigation"><ul class="flex items-center gap-1"><li><a class="rounded-md px-3 py-1.5 text-sm text-neutral-600 transition-colors hover:bg-neutral-100 hover:text-neutral-900 focus-visible:outline focus-visible:outline-2 focus-visible:outline-neutral-900 focus-visible:outline-offset-2" href="/rigidbodydynamicsai/research">Research</a></li></ul></nav><a target="_blank" rel="noopener noreferrer" class="ml-auto inline-flex h-9 flex-shrink-0 items-center justify-center gap-1.5 whitespace-nowrap rounded-md bg-foreground px-4 text-sm font-medium text-background transition-opacity hover:opacity-85 focus-visible:outline focus-visible:outline-2 focus-visible:outline-white focus-visible:outline-offset-2 sm:ml-1 sm:h-8" href="https://www.linkedin.com/company/rigid-body-dynamics-ai">Get in touch<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 16 16" fill="currentColor" class="h-3.5 w-3.5" aria-hidden="true"><path fill-rule="evenodd" d="M2 8a.75.75 0 0 1 .75-.75h8.69L8.22 4.03a.75.75 0 0 1 1.06-1.06l4.5 4.5a.75.75 0 0 1 0 1.06l-4.5 4.5a.75.75 0 0 1-1.06-1.06l3.22-3.22H2.75A.75.75 0 0 1 2 8Z" clip-rule="evenodd"></path></svg></a></div></header><main id="main"><div class="min-h-screen bg-white text-foreground"><main class="mx-auto max-w-3xl px-6 pt-28 pb-24"><nav class="mb-10 flex items-center gap-2 text-xs text-neutral-400"><a class="hover:text-neutral-600 transition-colors" href="/rigidbodydynamicsai">Home</a><span>/</span><a class="hover:text-neutral-600 transition-colors" href="/rigidbodydynamicsai/research">Research</a><span>/</span><a class="hover:text-neutral-600 transition-colors" href="/rigidbodydynamicsai/reports/market-opportunity-research">AI Market Opportunity Research</a><span>/</span><span class="text-neutral-500">Insurance Claim Denial Management</span></nav><p class="mb-3 text-xs font-medium uppercase tracking-widest text-neutral-400">Sub-research · February 2026</p><article class="prose-report markdown-report"><h1 class="text-3xl font-semibold leading-tight tracking-tight text-neutral-900 sm:text-4xl mt-0 mb-4">Insurance Claim Denial Management</h1>
<p class="text-[0.9375rem] leading-relaxed text-neutral-600 mb-4"><strong class="font-semibold text-neutral-800">Prepared:</strong> 2026-02-24
<strong class="font-semibold text-neutral-800">Data vintage:</strong> Primarily 2023-2025 sources (from analyst training data; live web verification was unavailable)
<strong class="font-semibold text-neutral-800">Caveat:</strong> WebSearch and WebFetch tools were blocked during this session. All figures below are drawn from the analyst&#x27;s training corpus (cut-off May 2025) and cite the original publication sources. Numbers should be independently verified before use in investment memos.</p>
<hr class="my-8 border-neutral-100"/>
<h2 class="text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28">1. PROBLEM MARKET SIZE</h2>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">Revenue at Risk from Claim Denials</h3>
<div class="my-6 overflow-x-auto rounded-lg border border-neutral-200"><table class="w-full text-sm"><thead class="border-b border-neutral-200 bg-neutral-50"><tr class="bg-white"><th class="px-4 py-3 text-left font-medium text-neutral-700">Metric</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Value</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Source</th></tr></thead><tbody class="divide-y divide-neutral-100"><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Total US hospital revenue billed to insurers (2024)</td><td class="px-4 py-3 text-neutral-600 align-top">~$1.5 trillion</td><td class="px-4 py-3 text-neutral-600 align-top">AHA Annual Survey / CMS NHE data</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Initial denial rate (industry average)</td><td class="px-4 py-3 text-neutral-600 align-top">10-15% of all claims; up to 20-25% at some systems</td><td class="px-4 py-3 text-neutral-600 align-top">HFMA 2023 &quot;Denial Benchmarking&quot; report; Experian Health 2024 survey</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Revenue initially denied</td><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">$150B - $225B annually</strong></td><td class="px-4 py-3 text-neutral-600 align-top">Derived from above</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Net write-off from denials (after appeals)</td><td class="px-4 py-3 text-neutral-600 align-top">~1.5-3% of net patient revenue</td><td class="px-4 py-3 text-neutral-600 align-top">HFMA; Crowe RCA benchmarking</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Estimated annual write-offs from denials</td><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">$20B - $45B</strong></td><td class="px-4 py-3 text-neutral-600 align-top">Derived; aligns with KFF and Advisory Board estimates</td></tr></tbody></table></div>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">Cost Hospitals Spend on Denial Management</h3>
<div class="my-6 overflow-x-auto rounded-lg border border-neutral-200"><table class="w-full text-sm"><thead class="border-b border-neutral-200 bg-neutral-50"><tr class="bg-white"><th class="px-4 py-3 text-left font-medium text-neutral-700">Metric</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Value</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Source</th></tr></thead><tbody class="divide-y divide-neutral-100"><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Average cost to rework/appeal a single denied claim</td><td class="px-4 py-3 text-neutral-600 align-top">$25 - $118 per claim (varies by complexity)</td><td class="px-4 py-3 text-neutral-600 align-top">AAPC 2023; Change Healthcare 2024 Revenue Cycle Index</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Estimated total industry spend on denial management (staff, appeals, outsourcing, write-offs combined)</td><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">$19.7B - $25B+</strong></td><td class="px-4 py-3 text-neutral-600 align-top">Becker&#x27;s Hospital Review 2023; derived from FTE and outsourcing data</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Average hospital employs dedicated denial FTEs</td><td class="px-4 py-3 text-neutral-600 align-top">15-50 FTEs per mid-large hospital system</td><td class="px-4 py-3 text-neutral-600 align-top">HFMA workforce surveys</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Avg fully loaded cost per denial management FTE</td><td class="px-4 py-3 text-neutral-600 align-top">$55,000 - $75,000/year</td><td class="px-4 py-3 text-neutral-600 align-top">Bureau of Labor Statistics; Becker&#x27;s</td></tr></tbody></table></div>
<p class="text-[0.9375rem] leading-relaxed text-neutral-600 mb-4"><strong class="font-semibold text-neutral-800">Bottom line:</strong> Denials put $150B-225B of hospital revenue at risk annually. Hospitals collectively spend $20B+ fighting them, and still write off $20B-45B.</p>
<hr class="my-8 border-neutral-100"/>
<h2 class="text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28">2. CURRENT SPEND TO MANAGE</h2>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">Revenue Cycle Management (RCM) Software Market</h3>
<div class="my-6 overflow-x-auto rounded-lg border border-neutral-200"><table class="w-full text-sm"><thead class="border-b border-neutral-200 bg-neutral-50"><tr class="bg-white"><th class="px-4 py-3 text-left font-medium text-neutral-700">Metric</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Value</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Source</th></tr></thead><tbody class="divide-y divide-neutral-100"><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">2023 market size</td><td class="px-4 py-3 text-neutral-600 align-top">$154B - $160B (includes services + software)</td><td class="px-4 py-3 text-neutral-600 align-top">Grand View Research 2024; Verified Market Research</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">2024 estimated</td><td class="px-4 py-3 text-neutral-600 align-top">~$176B</td><td class="px-4 py-3 text-neutral-600 align-top">Grand View Research</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">2030 forecast</td><td class="px-4 py-3 text-neutral-600 align-top">$329B - $398B</td><td class="px-4 py-3 text-neutral-600 align-top">Grand View Research; Fortune Business Insights</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">CAGR (2024-2030)</td><td class="px-4 py-3 text-neutral-600 align-top">10.3% - 11.5%</td><td class="px-4 py-3 text-neutral-600 align-top">Multiple analyst firms</td></tr></tbody></table></div>
<p class="text-[0.9375rem] leading-relaxed text-neutral-600 mb-4"><em>Note: The broader RCM market includes outsourced services, not just software. The software-only segment is a subset (~$20-25B in 2024).</em></p>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">Denial Management Software (Sub-Segment)</h3>
<div class="my-6 overflow-x-auto rounded-lg border border-neutral-200"><table class="w-full text-sm"><thead class="border-b border-neutral-200 bg-neutral-50"><tr class="bg-white"><th class="px-4 py-3 text-left font-medium text-neutral-700">Metric</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Value</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Source</th></tr></thead><tbody class="divide-y divide-neutral-100"><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">2023 estimated market size</td><td class="px-4 py-3 text-neutral-600 align-top">$4.5B - $5.5B</td><td class="px-4 py-3 text-neutral-600 align-top">Derived from Grand View Research RCM segmentation</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">CAGR</td><td class="px-4 py-3 text-neutral-600 align-top">12-14%</td><td class="px-4 py-3 text-neutral-600 align-top">Market Research Future; Allied Market Research</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">2030 forecast</td><td class="px-4 py-3 text-neutral-600 align-top">$10B - $13B</td><td class="px-4 py-3 text-neutral-600 align-top">Projected</td></tr></tbody></table></div>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">Medical Billing Outsourcing Market</h3>
<div class="my-6 overflow-x-auto rounded-lg border border-neutral-200"><table class="w-full text-sm"><thead class="border-b border-neutral-200 bg-neutral-50"><tr class="bg-white"><th class="px-4 py-3 text-left font-medium text-neutral-700">Metric</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Value</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Source</th></tr></thead><tbody class="divide-y divide-neutral-100"><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">2023 market size</td><td class="px-4 py-3 text-neutral-600 align-top">$13.5B - $14.8B</td><td class="px-4 py-3 text-neutral-600 align-top">Polaris Market Research; Grand View Research</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">CAGR (2024-2030)</td><td class="px-4 py-3 text-neutral-600 align-top">10.1% - 12.3%</td><td class="px-4 py-3 text-neutral-600 align-top">Multiple sources</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">2030 forecast</td><td class="px-4 py-3 text-neutral-600 align-top">$26B - $30B</td><td class="px-4 py-3 text-neutral-600 align-top">Projected</td></tr></tbody></table></div>
<hr class="my-8 border-neutral-100"/>
<h2 class="text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28">3. COST OF INACTION</h2>
<div class="my-6 overflow-x-auto rounded-lg border border-neutral-200"><table class="w-full text-sm"><thead class="border-b border-neutral-200 bg-neutral-50"><tr class="bg-white"><th class="px-4 py-3 text-left font-medium text-neutral-700">Metric</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Value</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Source</th></tr></thead><tbody class="divide-y divide-neutral-100"><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">% of denied claims never appealed</td><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">50-65%</strong></td><td class="px-4 py-3 text-neutral-600 align-top">Premier Inc. 2023 analysis; Advisory Board 2024</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Reason most not appealed</td><td class="px-4 py-3 text-neutral-600 align-top">Cost-to-appeal exceeds claim value, or staff bandwidth exhausted</td><td class="px-4 py-3 text-neutral-600 align-top">HFMA</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Average cost to work one denial</td><td class="px-4 py-3 text-neutral-600 align-top">$25 (simple) to $118 (complex/clinical)</td><td class="px-4 py-3 text-neutral-600 align-top">Change Healthcare 2024 Index; AAPC</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Average cost to file a formal appeal</td><td class="px-4 py-3 text-neutral-600 align-top">$48 - $118 per claim</td><td class="px-4 py-3 text-neutral-600 align-top">AAPC; Experian Health</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Revenue lost from uncontested denials annually</td><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">$10B - $27B</strong> (est. 50-65% of $20B-$45B write-off pool)</td><td class="px-4 py-3 text-neutral-600 align-top">Derived</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Appeal overturn/success rate (when pursued)</td><td class="px-4 py-3 text-neutral-600 align-top">50-70%</td><td class="px-4 py-3 text-neutral-600 align-top">MGMA 2023; HFMA</td></tr></tbody></table></div>
<p class="text-[0.9375rem] leading-relaxed text-neutral-600 mb-4"><strong class="font-semibold text-neutral-800">Key insight:</strong> More than half of denied claims are never contested, yet when hospitals do appeal, they win 50-70% of the time. This represents a massive recoverable revenue pool that is abandoned due to operational capacity constraints.</p>
<hr class="my-8 border-neutral-100"/>
<h2 class="text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28">4. VOLUME FREQUENCY</h2>
<div class="my-6 overflow-x-auto rounded-lg border border-neutral-200"><table class="w-full text-sm"><thead class="border-b border-neutral-200 bg-neutral-50"><tr class="bg-white"><th class="px-4 py-3 text-left font-medium text-neutral-700">Metric</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Value</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Source</th></tr></thead><tbody class="divide-y divide-neutral-100"><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Total medical claims submitted/year (US, all payers)</td><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">~6 billion</strong> claims (professional + institutional combined)</td><td class="px-4 py-3 text-neutral-600 align-top">CAQH 2024 Index; CMS data</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Hospital/facility claims specifically</td><td class="px-4 py-3 text-neutral-600 align-top">~1.2 - 1.5 billion</td><td class="px-4 py-3 text-neutral-600 align-top">AHA; derived from CMS</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Initial denial rate (all claims)</td><td class="px-4 py-3 text-neutral-600 align-top">10-15%</td><td class="px-4 py-3 text-neutral-600 align-top">Experian Health 2024; Change Healthcare</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Initial denial rate (hospital inpatient)</td><td class="px-4 py-3 text-neutral-600 align-top">15-25% (higher complexity)</td><td class="px-4 py-3 text-neutral-600 align-top">HFMA 2023; KFF</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Claims denied on first submission annually</td><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">~200-350 million</strong> hospital claims</td><td class="px-4 py-3 text-neutral-600 align-top">Derived</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Prior authorization denial rate (Medicare Advantage)</td><td class="px-4 py-3 text-neutral-600 align-top">13-18% of prior auth requests</td><td class="px-4 py-3 text-neutral-600 align-top">KFF 2024 Medicare Advantage report; OIG</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Appeals filed as % of denials</td><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">35-50%</strong></td><td class="px-4 py-3 text-neutral-600 align-top">Premier; Advisory Board</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Estimated appeals filed annually (hospital)</td><td class="px-4 py-3 text-neutral-600 align-top">~70-175 million</td><td class="px-4 py-3 text-neutral-600 align-top">Derived</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Average time to resolve a denial (rework + appeal)</td><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">30-60 days</strong> (simple); <strong class="font-semibold text-neutral-800">90-180+ days</strong> (complex/multi-level appeal)</td><td class="px-4 py-3 text-neutral-600 align-top">HFMA; Waystar benchmarking data</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Average days in A/R for denied claims</td><td class="px-4 py-3 text-neutral-600 align-top">45-90 days beyond initial billing cycle</td><td class="px-4 py-3 text-neutral-600 align-top">MGMA benchmarks</td></tr></tbody></table></div>
<hr class="my-8 border-neutral-100"/>
<h2 class="text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28">5. WHY STILL UNSOLVED</h2>
<p class="text-[0.9375rem] leading-relaxed text-neutral-600 mb-4">Despite billions invested in RCM technology, denial rates have <strong class="font-semibold text-neutral-800">risen ~23% over the past decade</strong> (Change Healthcare Index, 2024). Key structural reasons:</p>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">5.1 Payer Algorithm Changes (Moving Target Problem)</h3>
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed">Insurers continuously update clinical criteria, coverage policies, and prior auth rules</li>
<li class="leading-relaxed">Medicare Advantage plans use proprietary AI/ML algorithms to auto-adjudicate (and auto-deny) claims</li>
<li class="leading-relaxed">OIG found MA plans denied 13-18% of prior auths, many of which met Medicare coverage criteria</li>
<li class="leading-relaxed">Payer rule changes outpace provider RCM software update cycles</li>
</ul>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">5.2 Coding Complexity Explosion</h3>
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed">ICD-10 has ~72,000 diagnosis codes vs. ~14,000 in ICD-9</li>
<li class="leading-relaxed">CPT code updates annually (300+ changes/year)</li>
<li class="leading-relaxed">Modifier requirements increasingly complex</li>
<li class="leading-relaxed">Clinical documentation must precisely match coding requirements</li>
</ul>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">5.3 Staff Turnover and Workforce Crisis</h3>
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed">Medical coder/biller turnover: 25-40% annually (AAPC 2024 salary survey)</li>
<li class="leading-relaxed">Average time to train a denial management specialist: 6-12 months</li>
<li class="leading-relaxed">Post-COVID burnout accelerated departures from revenue cycle roles</li>
<li class="leading-relaxed">Experienced coders retiring faster than replacements entering</li>
</ul>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">5.4 Data Fragmentation</h3>
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed">Average hospital uses 15+ disparate systems (EHR, PM, clearinghouse, payer portals)</li>
<li class="leading-relaxed">Lack of real-time eligibility/benefit verification at point of care</li>
<li class="leading-relaxed">Clinical documentation lives in EHR; billing data in PM system; payer rules on external portals</li>
<li class="leading-relaxed">No single source of truth connecting clinical, financial, and payer data</li>
</ul>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">5.5 Misaligned Incentives</h3>
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed">Payers benefit financially from denials (float, write-offs)</li>
<li class="leading-relaxed">Payers face minimal penalties for inappropriate denials</li>
<li class="leading-relaxed">Provider appeals process is deliberately cumbersome</li>
<li class="leading-relaxed">CMS has been slow to enforce payer accountability</li>
</ul>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">5.6 Legacy RCM Software Limitations</h3>
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed">Most RCM platforms are rules-based, not predictive</li>
<li class="leading-relaxed">Retrospective denial tracking vs. prospective denial prevention</li>
<li class="leading-relaxed">Batch processing vs. real-time intervention</li>
<li class="leading-relaxed">Limited NLP/AI capability for clinical documentation analysis</li>
</ul>
<hr class="my-8 border-neutral-100"/>
<h2 class="text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28">6. WILLINGNESS TO PAY SIGNALS</h2>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">What Hospitals Pay Today</h3>
<div class="my-6 overflow-x-auto rounded-lg border border-neutral-200"><table class="w-full text-sm"><thead class="border-b border-neutral-200 bg-neutral-50"><tr class="bg-white"><th class="px-4 py-3 text-left font-medium text-neutral-700">Category</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Annual Spend</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Source</th></tr></thead><tbody class="divide-y divide-neutral-100"><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">In-house RCM team (avg mid-size hospital, ~50 FTEs)</td><td class="px-4 py-3 text-neutral-600 align-top">$3M - $5M/year</td><td class="px-4 py-3 text-neutral-600 align-top">BLS; HFMA</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">In-house RCM team (large health system, 200+ FTEs)</td><td class="px-4 py-3 text-neutral-600 align-top">$12M - $20M/year</td><td class="px-4 py-3 text-neutral-600 align-top">Becker&#x27;s</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Outsourced RCM services (% of collections model)</td><td class="px-4 py-3 text-neutral-600 align-top">4-8% of net patient revenue</td><td class="px-4 py-3 text-neutral-600 align-top">HFMA; vendor benchmarks</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Outsourced RCM for a $500M revenue hospital</td><td class="px-4 py-3 text-neutral-600 align-top">$20M - $40M/year</td><td class="px-4 py-3 text-neutral-600 align-top">Derived</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Denial management software (per-provider pricing)</td><td class="px-4 py-3 text-neutral-600 align-top">$50K - $500K/year per facility</td><td class="px-4 py-3 text-neutral-600 align-top">Vendor pricing; KLAS</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">AI-powered denial prevention platforms</td><td class="px-4 py-3 text-neutral-600 align-top">$200K - $1M+/year per health system</td><td class="px-4 py-3 text-neutral-600 align-top">KLAS 2024; vendor data</td></tr></tbody></table></div>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">VC/PE Investment Activity (2023-2025)</h3>
<div class="my-6 overflow-x-auto rounded-lg border border-neutral-200"><table class="w-full text-sm"><thead class="border-b border-neutral-200 bg-neutral-50"><tr class="bg-white"><th class="px-4 py-3 text-left font-medium text-neutral-700">Company / Deal</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Amount</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Date</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Investor(s)</th></tr></thead><tbody class="divide-y divide-neutral-100"><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Waystar IPO</td><td class="px-4 py-3 text-neutral-600 align-top">~$968M raised (IPO)</td><td class="px-4 py-3 text-neutral-600 align-top">June 2024</td><td class="px-4 py-3 text-neutral-600 align-top">Public markets (backed by EQT, CPPIB)</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Akasa (AI for RCM)</td><td class="px-4 py-3 text-neutral-600 align-top">$60M Series B</td><td class="px-4 py-3 text-neutral-600 align-top">2023</td><td class="px-4 py-3 text-neutral-600 align-top">Andreessen Horowitz (a16z)</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">AKASA total raised</td><td class="px-4 py-3 text-neutral-600 align-top">$120M+</td><td class="px-4 py-3 text-neutral-600 align-top">Through 2024</td><td class="px-4 py-3 text-neutral-600 align-top">a16z, BOND, others</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Olive AI (RCM automation)</td><td class="px-4 py-3 text-neutral-600 align-top">Wound down; assets acquired by Waystar, others</td><td class="px-4 py-3 text-neutral-600 align-top">2023</td><td class="px-4 py-3 text-neutral-600 align-top">Previously raised $900M+</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Infinx (AI prior auth)</td><td class="px-4 py-3 text-neutral-600 align-top">$75M+ total</td><td class="px-4 py-3 text-neutral-600 align-top">2023-2024</td><td class="px-4 py-3 text-neutral-600 align-top">Multiple PE/VC</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Apixio/ClaimLogiq (AI denials)</td><td class="px-4 py-3 text-neutral-600 align-top">Acquired by New Mountain Capital</td><td class="px-4 py-3 text-neutral-600 align-top">2023</td><td class="px-4 py-3 text-neutral-600 align-top">PE</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">R1 RCM</td><td class="px-4 py-3 text-neutral-600 align-top">Acquired by TowerBrook/CD&amp;R for $8.9B</td><td class="px-4 py-3 text-neutral-600 align-top">2024</td><td class="px-4 py-3 text-neutral-600 align-top">PE</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Ensemble Health Partners</td><td class="px-4 py-3 text-neutral-600 align-top">Acquired by Bon Secours for strategic partnership</td><td class="px-4 py-3 text-neutral-600 align-top">2024</td><td class="px-4 py-3 text-neutral-600 align-top">Health system</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Nividous / Autonomize AI</td><td class="px-4 py-3 text-neutral-600 align-top">$15-30M rounds for RCM AI startups</td><td class="px-4 py-3 text-neutral-600 align-top">2023-2024</td><td class="px-4 py-3 text-neutral-600 align-top">Various VC</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Medallion (credentialing/RCM adjacent)</td><td class="px-4 py-3 text-neutral-600 align-top">$44M Series C</td><td class="px-4 py-3 text-neutral-600 align-top">2024</td><td class="px-4 py-3 text-neutral-600 align-top">Various</td></tr></tbody></table></div>
<p class="text-[0.9375rem] leading-relaxed text-neutral-600 mb-4"><strong class="font-semibold text-neutral-800">Signal strength:</strong> The R1 RCM acquisition at $8.9B and Waystar IPO at ~$3.7B market cap on listing day demonstrate massive PE/public market appetite. Multiple AI-native startups raising $50M-$120M rounds specifically for denial management signals strong WTP for next-gen solutions.</p>
<hr class="my-8 border-neutral-100"/>
<h2 class="text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28">7. MARKET GROWTH RATE</h2>
<div class="my-6 overflow-x-auto rounded-lg border border-neutral-200"><table class="w-full text-sm"><thead class="border-b border-neutral-200 bg-neutral-50"><tr class="bg-white"><th class="px-4 py-3 text-left font-medium text-neutral-700">Segment</th><th class="px-4 py-3 text-left font-medium text-neutral-700">2024 Size (Est.)</th><th class="px-4 py-3 text-left font-medium text-neutral-700">2030 Forecast</th><th class="px-4 py-3 text-left font-medium text-neutral-700">CAGR</th></tr></thead><tbody class="divide-y divide-neutral-100"><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Total RCM Market (services + software)</td><td class="px-4 py-3 text-neutral-600 align-top">$176B</td><td class="px-4 py-3 text-neutral-600 align-top">$329B - $398B</td><td class="px-4 py-3 text-neutral-600 align-top">10.3% - 11.5%</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">RCM Software Only</td><td class="px-4 py-3 text-neutral-600 align-top">$20B - $25B</td><td class="px-4 py-3 text-neutral-600 align-top">$48B - $55B</td><td class="px-4 py-3 text-neutral-600 align-top">11% - 13%</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Denial Management Software</td><td class="px-4 py-3 text-neutral-600 align-top">$5B - $6B</td><td class="px-4 py-3 text-neutral-600 align-top">$10B - $13B</td><td class="px-4 py-3 text-neutral-600 align-top">12% - 14%</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">Medical Billing Outsourcing</td><td class="px-4 py-3 text-neutral-600 align-top">$14B - $15B</td><td class="px-4 py-3 text-neutral-600 align-top">$26B - $30B</td><td class="px-4 py-3 text-neutral-600 align-top">10% - 12%</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top">AI in Healthcare RCM (sub-segment)</td><td class="px-4 py-3 text-neutral-600 align-top">$2B - $3B</td><td class="px-4 py-3 text-neutral-600 align-top">$8B - $12B</td><td class="px-4 py-3 text-neutral-600 align-top">20% - 25%</td></tr></tbody></table></div>
<p class="text-[0.9375rem] leading-relaxed text-neutral-600 mb-4"><strong class="font-semibold text-neutral-800">Key growth drivers:</strong></p>
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed">Regulatory complexity increasing (No Surprises Act, prior auth reform)</li>
<li class="leading-relaxed">Labor shortages forcing automation adoption</li>
<li class="leading-relaxed">Medicare Advantage enrollment growth (more complex payer mix)</li>
<li class="leading-relaxed">AI/ML maturation enabling predictive denial prevention</li>
<li class="leading-relaxed">CMS interoperability mandates creating data availability</li>
</ul>
<hr class="my-8 border-neutral-100"/>
<h2 class="text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28">8. KEY PLAYERS TODAY</h2>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">Major RCM / Denial Management Companies</h3>
<div class="my-6 overflow-x-auto rounded-lg border border-neutral-200"><table class="w-full text-sm"><thead class="border-b border-neutral-200 bg-neutral-50"><tr class="bg-white"><th class="px-4 py-3 text-left font-medium text-neutral-700">Company</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Est. Revenue (2024)</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Segment Focus</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Notes</th></tr></thead><tbody class="divide-y divide-neutral-100"><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">Waystar</strong></td><td class="px-4 py-3 text-neutral-600 align-top">~$770M-$850M</td><td class="px-4 py-3 text-neutral-600 align-top">RCM software, clearinghouse, denial mgmt</td><td class="px-4 py-3 text-neutral-600 align-top">IPO June 2024; EQT-backed; acquired Olive AI assets</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">R1 RCM</strong></td><td class="px-4 py-3 text-neutral-600 align-top">~$2.2B</td><td class="px-4 py-3 text-neutral-600 align-top">End-to-end RCM outsourcing + tech</td><td class="px-4 py-3 text-neutral-600 align-top">Acquired by TowerBrook/CD&amp;R for $8.9B (2024)</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">Cotiviti</strong> (Verscend)</td><td class="px-4 py-3 text-neutral-600 align-top">~$1.0B-$1.2B</td><td class="px-4 py-3 text-neutral-600 align-top">Payment accuracy, analytics, risk adjustment</td><td class="px-4 py-3 text-neutral-600 align-top">Owned by Veritas Capital; serves payer + provider</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">Change Healthcare</strong> (Optum)</td><td class="px-4 py-3 text-neutral-600 align-top">~$3.5B+ (segment)</td><td class="px-4 py-3 text-neutral-600 align-top">Clearinghouse, RCM, payment integrity</td><td class="px-4 py-3 text-neutral-600 align-top">Part of UnitedHealth/Optum after $7.8B acquisition (2022); major cyberattack Feb 2024</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">nThrive</strong> (now part of R1 RCM)</td><td class="px-4 py-3 text-neutral-600 align-top">Folded into R1</td><td class="px-4 py-3 text-neutral-600 align-top">Coding, CDI, denial management</td><td class="px-4 py-3 text-neutral-600 align-top">Merged with R1 RCM</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">Omega Healthcare</strong></td><td class="px-4 py-3 text-neutral-600 align-top">~$500M-$700M</td><td class="px-4 py-3 text-neutral-600 align-top">RCM outsourcing (India-based operations)</td><td class="px-4 py-3 text-neutral-600 align-top">Large offshore BPO for RCM</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">Ensemble Health Partners</strong></td><td class="px-4 py-3 text-neutral-600 align-top">~$1.0B+</td><td class="px-4 py-3 text-neutral-600 align-top">End-to-end RCM outsourcing</td><td class="px-4 py-3 text-neutral-600 align-top">Strategic deals with health systems</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">GeBBS Healthcare</strong></td><td class="px-4 py-3 text-neutral-600 align-top">~$200M-$300M</td><td class="px-4 py-3 text-neutral-600 align-top">RCM outsourcing, coding</td><td class="px-4 py-3 text-neutral-600 align-top">India-based</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">AGS Health</strong></td><td class="px-4 py-3 text-neutral-600 align-top">~$150M-$250M</td><td class="px-4 py-3 text-neutral-600 align-top">RCM outsourcing, denial management</td><td class="px-4 py-3 text-neutral-600 align-top">India-based</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">Experian Health</strong></td><td class="px-4 py-3 text-neutral-600 align-top">~$500M-$700M (health segment)</td><td class="px-4 py-3 text-neutral-600 align-top">Eligibility, claims, patient access</td><td class="px-4 py-3 text-neutral-600 align-top">Part of Experian plc</td></tr></tbody></table></div>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">AI-Native Disruptors</h3>
<div class="my-6 overflow-x-auto rounded-lg border border-neutral-200"><table class="w-full text-sm"><thead class="border-b border-neutral-200 bg-neutral-50"><tr class="bg-white"><th class="px-4 py-3 text-left font-medium text-neutral-700">Company</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Funding / Stage</th><th class="px-4 py-3 text-left font-medium text-neutral-700">Focus</th></tr></thead><tbody class="divide-y divide-neutral-100"><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">AKASA</strong></td><td class="px-4 py-3 text-neutral-600 align-top">$120M+ raised</td><td class="px-4 py-3 text-neutral-600 align-top">AI-powered RCM automation</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">Infinx</strong></td><td class="px-4 py-3 text-neutral-600 align-top">$75M+ raised</td><td class="px-4 py-3 text-neutral-600 align-top">AI prior authorization</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">Apixio / ClaimLogiq</strong></td><td class="px-4 py-3 text-neutral-600 align-top">PE-backed (New Mountain)</td><td class="px-4 py-3 text-neutral-600 align-top">AI-powered denial management</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">Adonis</strong></td><td class="px-4 py-3 text-neutral-600 align-top">~$20M+ raised</td><td class="px-4 py-3 text-neutral-600 align-top">AI denial prevention for physician groups</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">Rhyme Health</strong></td><td class="px-4 py-3 text-neutral-600 align-top">Early stage</td><td class="px-4 py-3 text-neutral-600 align-top">AI denial appeals automation</td></tr><tr class="bg-white"><td class="px-4 py-3 text-neutral-600 align-top"><strong class="font-semibold text-neutral-800">Valer</strong></td><td class="px-4 py-3 text-neutral-600 align-top">Early stage</td><td class="px-4 py-3 text-neutral-600 align-top">Denial prediction and prevention</td></tr></tbody></table></div>
<hr class="my-8 border-neutral-100"/>
<h2 class="text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28">9. KEY SOURCES</h2>
<p class="text-[0.9375rem] leading-relaxed text-neutral-600 mb-4">All sources referenced in this report. Note: URLs are provided as best-known links; some may require subscription access.</p>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">Industry Associations and Government</h3>
<ol class="list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">HFMA (Healthcare Financial Management Association)</strong> - Denial benchmarking reports and workforce surveys<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.hfma.org/topics/financial-sustainability/">https://www.hfma.org/topics/financial-sustainability/</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">KFF (Kaiser Family Foundation)</strong> - Medicare Advantage denial data<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.kff.org/medicare/issue-brief/over-35-million-prior-authorization-requests-were-submitted-to-medicare-advantage-plans-in-2021/">https://www.kff.org/medicare/issue-brief/over-35-million-prior-authorization-requests-were-submitted-to-medicare-advantage-plans-in-2021/</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">CMS National Health Expenditure Data</strong> - Total healthcare spending<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data">https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">OIG (HHS Office of Inspector General)</strong> - MA denial investigations<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://oig.hhs.gov/reports/">https://oig.hhs.gov/reports/</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">AHA (American Hospital Association)</strong> - Hospital statistics<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.aha.org/statistics">https://www.aha.org/statistics</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">CAQH Index</strong> - Claims volume and automation data<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.caqh.org/explorations/caqh-index">https://www.caqh.org/explorations/caqh-index</a></li>
</ul>
</li>
</ol>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">Market Research Firms</h3>
<ol class="list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">Grand View Research</strong> - RCM market analysis<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.grandviewresearch.com/industry-analysis/revenue-cycle-management-market">https://www.grandviewresearch.com/industry-analysis/revenue-cycle-management-market</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">Fortune Business Insights</strong> - RCM market forecast<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.fortunebusinessinsights.com/revenue-cycle-management-market-103045">https://www.fortunebusinessinsights.com/revenue-cycle-management-market-103045</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">Polaris Market Research</strong> - Medical billing outsourcing<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.polarismarketresearch.com/industry-analysis/medical-billing-outsourcing-market">https://www.polarismarketresearch.com/industry-analysis/medical-billing-outsourcing-market</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">Allied Market Research</strong> - Denial management market<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.alliedmarketresearch.com/">https://www.alliedmarketresearch.com/</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">Market Research Future</strong> - Healthcare RCM<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.marketresearchfuture.com/">https://www.marketresearchfuture.com/</a></li>
</ul>
</li>
</ol>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">Industry Publications and Data</h3>
<ol class="list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">Change Healthcare / Optum Revenue Cycle Index</strong> - Denial rate trends and cost-to-appeal data<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.changehealthcare.com/insights/revenue-cycle-denials-index">https://www.changehealthcare.com/insights/revenue-cycle-denials-index</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">Experian Health</strong> - State of Claims survey (2024)<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.experian.com/healthcare/">https://www.experian.com/healthcare/</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">Becker&#x27;s Hospital Review</strong> - RCM workforce and spending<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.beckershospitalreview.com/finance/">https://www.beckershospitalreview.com/finance/</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">Fierce Healthcare</strong> - Denial rate trends<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.fiercehealthcare.com/finance">https://www.fiercehealthcare.com/finance</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">KLAS Research</strong> - RCM software vendor ratings<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://klasresearch.com/">https://klasresearch.com/</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">Advisory Board (Optum)</strong> - Denial management analytics<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.advisory.com/topics/revenue-cycle-management">https://www.advisory.com/topics/revenue-cycle-management</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">Premier Inc.</strong> - Denial analytics and benchmarking<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.premierinc.com/">https://www.premierinc.com/</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">AAPC</strong> - Coding workforce and salary data<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.aapc.com/">https://www.aapc.com/</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">MGMA</strong> - Practice management benchmarks<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.mgma.com/">https://www.mgma.com/</a></li>
</ul>
</li>
</ol>
<h3 class="text-base font-medium text-neutral-800 mt-10 mb-3">Deal / Investment Sources</h3>
<ol class="list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">Waystar S-1 / IPO Filing</strong> - SEC Edgar<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;company=waystar">https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;company=waystar</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">R1 RCM Take-Private</strong> - Press coverage<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.beckershospitalreview.com/finance/r1-rcm-acquired-for-8-9b.html">https://www.beckershospitalreview.com/finance/r1-rcm-acquired-for-8-9b.html</a></li>
</ul>
</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">AKASA Funding</strong> - Crunchbase / press releases<!-- -->
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><a href="https://www.akasa.com/">https://www.akasa.com/</a></li>
</ul>
</li>
</ol>
<hr class="my-8 border-neutral-100"/>
<h2 class="text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28">EXECUTIVE SUMMARY</h2>
<p class="text-[0.9375rem] leading-relaxed text-neutral-600 mb-4">The US insurance claim denial management problem represents one of the largest inefficiencies in healthcare:</p>
<ul class="list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4">
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">$150B-$225B</strong> in hospital revenue is initially denied annually</li>
<li class="leading-relaxed"><strong class="font-semibold text-neutral-800">$20B-$45B</strong> is permanently written off, with <strong class="font-semibold text-neutral-800">50-65% of denials never even appealed</strong></li>
<li class="leading-relaxed">When hospitals do appeal, they win <strong class="font-semibold text-neutral-800">50-70% of the time</strong> -- revealing a massive recoverable revenue pool abandoned due to operational constraints</li>
<li class="leading-relaxed">Hospitals spend <strong class="font-semibold text-neutral-800">$20B+ annually</strong> on denial management through a combination of in-house staff, outsourced services, and technology</li>
<li class="leading-relaxed">The RCM market is growing at <strong class="font-semibold text-neutral-800">10-13% CAGR</strong> with AI-specific sub-segments growing at <strong class="font-semibold text-neutral-800">20-25%</strong></li>
<li class="leading-relaxed">PE/VC conviction is high: <strong class="font-semibold text-neutral-800">R1 RCM acquired for $8.9B</strong>, <strong class="font-semibold text-neutral-800">Waystar IPO at ~$3.7B</strong>, and <strong class="font-semibold text-neutral-800">$200M+ deployed into AI-native denial management startups</strong> in 2023-2024</li>
</ul>
<p class="text-[0.9375rem] leading-relaxed text-neutral-600 mb-4">The problem persists because it is structurally adversarial (payers benefit from denials), operationally complex (72,000 ICD-10 codes, constantly changing payer rules), and plagued by workforce challenges (25-40% coder turnover). Legacy RCM tools are rules-based and retrospective. The market is ripe for AI-native solutions that can predict denials before submission, auto-generate appeals, and adapt in real-time to payer algorithm changes.</p>
<p class="text-[0.9375rem] leading-relaxed text-neutral-600 mb-4"><strong class="font-semibold text-neutral-800">Largest opportunity vector:</strong> Converting the 50-65% of denials that are currently abandoned into appealed and recovered revenue using AI-powered automation. At a 60% appeal success rate, this represents <strong class="font-semibold text-neutral-800">$6B-$16B in recoverable revenue annually</strong> -- a value proposition that can support premium SaaS pricing.</p></article><div class="mt-16 flex flex-wrap items-center gap-4 border-t border-neutral-100 pt-8"><a class="inline-flex items-center gap-1.5 text-sm text-neutral-500 hover:text-neutral-900 transition-colors group" href="/rigidbodydynamicsai/reports/market-opportunity-research"><span class="transition-transform group-hover:-translate-x-0.5">←</span>Back to AI Market Opportunity Research</a><span class="text-neutral-300">·</span><a class="inline-flex items-center gap-1.5 text-sm text-neutral-500 hover:text-neutral-900 transition-colors group" href="/rigidbodydynamicsai/research"><span class="transition-transform group-hover:-translate-x-0.5">←</span>Back to Research</a></div></main></div><!--$--><!--/$--></main><script src="/rigidbodydynamicsai/_next/static/chunks/e9bfe6dd4a921662.js" id="_R_" async=""></script><script>(self.__next_f=self.__next_f||[]).push([0])</script><script>self.__next_f.push([1,"1:\"$Sreact.fragment\"\n2:I[97280,[\"/rigidbodydynamicsai/_next/static/chunks/8461251ea68c7ff3.js\"],\"default\"]\n3:I[39756,[\"/rigidbodydynamicsai/_next/static/chunks/ff1a16fafef87110.js\",\"/rigidbodydynamicsai/_next/static/chunks/d2be314c3ece3fbe.js\"],\"default\"]\n4:I[37457,[\"/rigidbodydynamicsai/_next/static/chunks/ff1a16fafef87110.js\",\"/rigidbodydynamicsai/_next/static/chunks/d2be314c3ece3fbe.js\"],\"default\"]\n6:I[97367,[\"/rigidbodydynamicsai/_next/static/chunks/ff1a16fafef87110.js\",\"/rigidbodydynamicsai/_next/static/chunks/d2be314c3ece3fbe.js\"],\"OutletBoundary\"]\n7:\"$Sreact.suspense\"\n9:I[97367,[\"/rigidbodydynamicsai/_next/static/chunks/ff1a16fafef87110.js\",\"/rigidbodydynamicsai/_next/static/chunks/d2be314c3ece3fbe.js\"],\"ViewportBoundary\"]\nb:I[97367,[\"/rigidbodydynamicsai/_next/static/chunks/ff1a16fafef87110.js\",\"/rigidbodydynamicsai/_next/static/chunks/d2be314c3ece3fbe.js\"],\"MetadataBoundary\"]\nd:I[68027,[],\"default\"]\n:HL[\"/rigidbodydynamicsai/_next/static/chunks/43c443004b697646.css\",\"style\"]\n:HL[\"/rigidbodydynamicsai/_next/static/media/01d67e7cc17e7674-s.p.5b396bc1.woff2\",\"font\",{\"crossOrigin\":\"\",\"type\":\"font/woff2\"}]\n:HL[\"/rigidbodydynamicsai/_next/static/media/2a65768255d6b625-s.p.d19752fb.woff2\",\"font\",{\"crossOrigin\":\"\",\"type\":\"font/woff2\"}]\n:HL[\"/rigidbodydynamicsai/_next/static/media/797e433ab948586e-s.p.dbea232f.woff2\",\"font\",{\"crossOrigin\":\"\",\"type\":\"font/woff2\"}]\n:HL[\"/rigidbodydynamicsai/_next/static/media/caa3a2e1cccd8315-s.p.853070df.woff2\",\"font\",{\"crossOrigin\":\"\",\"type\":\"font/woff2\"}]\n"])</script><script>self.__next_f.push([1,"0:{\"P\":null,\"b\":\"8nmnW_8LUcQxaBO0rEWXk\",\"c\":[\"\",\"reports\",\"market-opportunity-research\",\"hc_05_claim_denials\"],\"q\":\"\",\"i\":false,\"f\":[[[\"\",{\"children\":[\"reports\",{\"children\":[\"market-opportunity-research\",{\"children\":[[\"slug\",\"hc_05_claim_denials\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]}]},\"$undefined\",\"$undefined\",true],[[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/rigidbodydynamicsai/_next/static/chunks/43c443004b697646.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"$undefined\"}],[\"$\",\"script\",\"script-0\",{\"src\":\"/rigidbodydynamicsai/_next/static/chunks/8461251ea68c7ff3.js\",\"async\":true,\"nonce\":\"$undefined\"}]],[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"light\",\"children\":[\"$\",\"body\",null,{\"className\":\"geist_a71539c9-module__T19VSG__variable geist_mono_8d43a2aa-module__8Li5zG__variable playfair_display_44985fd-module__vl415q__variable pixelify_sans_8b7fe3b4-module__eZKBvW__variable antialiased font-sans bg-background text-foreground\",\"children\":[[\"$\",\"a\",null,{\"href\":\"#main\",\"className\":\"sr-only focus-visible:not-sr-only focus-visible:absolute focus-visible:left-4 focus-visible:top-4 focus-visible:z-50 focus-visible:rounded focus-visible:bg-accent focus-visible:px-4 focus-visible:py-2 focus-visible:text-accent-foreground\",\"children\":\"Skip to main content\"}],[\"$\",\"$L2\",null,{}],[\"$\",\"main\",null,{\"id\":\"main\",\"children\":[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[[\"$\",\"title\",null,{\"children\":\"404: This page could not be found.\"}],[\"$\",\"div\",null,{\"style\":{\"fontFamily\":\"system-ui,\\\"Segoe UI\\\",Roboto,Helvetica,Arial,sans-serif,\\\"Apple Color Emoji\\\",\\\"Segoe UI Emoji\\\"\",\"height\":\"100vh\",\"textAlign\":\"center\",\"display\":\"flex\",\"flexDirection\":\"column\",\"alignItems\":\"center\",\"justifyContent\":\"center\"},\"children\":[\"$\",\"div\",null,{\"children\":[[\"$\",\"style\",null,{\"dangerouslySetInnerHTML\":{\"__html\":\"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}\"}}],[\"$\",\"h1\",null,{\"className\":\"next-error-h1\",\"style\":{\"display\":\"inline-block\",\"margin\":\"0 20px 0 0\",\"padding\":\"0 23px 0 0\",\"fontSize\":24,\"fontWeight\":500,\"verticalAlign\":\"top\",\"lineHeight\":\"49px\"},\"children\":404}],[\"$\",\"div\",null,{\"style\":{\"display\":\"inline-block\"},\"children\":[\"$\",\"h2\",null,{\"style\":{\"fontSize\":14,\"fontWeight\":400,\"lineHeight\":\"49px\",\"margin\":0},\"children\":\"This page could not be found.\"}]}]]}]}]],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]}]]}]}]]}],{\"children\":[[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"$\",\"$1\",\"c\",{\"children\":[\"$L5\",null,[\"$\",\"$L6\",null,{\"children\":[\"$\",\"$7\",null,{\"name\":\"Next.MetadataOutlet\",\"children\":\"$@8\"}]}]]}],{},null,false,false]},null,false,false]},null,false,false]},null,false,false]},null,false,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[\"$\",\"$L9\",null,{\"children\":\"$La\"}],[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$Lb\",null,{\"children\":[\"$\",\"$7\",null,{\"name\":\"Next.Metadata\",\"children\":\"$Lc\"}]}]}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$d\",[]],\"S\":true}\n"])</script><script>self.__next_f.push([1,"e:I[22016,[\"/rigidbodydynamicsai/_next/static/chunks/8461251ea68c7ff3.js\"],\"\"]\n"])</script><script>self.__next_f.push([1,"5:[\"$\",\"div\",null,{\"className\":\"min-h-screen bg-white text-foreground\",\"children\":[\"$\",\"main\",null,{\"className\":\"mx-auto max-w-3xl px-6 pt-28 pb-24\",\"children\":[[\"$\",\"nav\",null,{\"className\":\"mb-10 flex items-center gap-2 text-xs text-neutral-400\",\"children\":[[\"$\",\"$Le\",null,{\"href\":\"/\",\"className\":\"hover:text-neutral-600 transition-colors\",\"children\":\"Home\"}],[\"$\",\"span\",null,{\"children\":\"/\"}],[\"$\",\"$Le\",null,{\"href\":\"/research\",\"className\":\"hover:text-neutral-600 transition-colors\",\"children\":\"Research\"}],[\"$\",\"span\",null,{\"children\":\"/\"}],[\"$\",\"$Le\",null,{\"href\":\"/reports/market-opportunity-research\",\"className\":\"hover:text-neutral-600 transition-colors\",\"children\":\"AI Market Opportunity Research\"}],[\"$\",\"span\",null,{\"children\":\"/\"}],[\"$\",\"span\",null,{\"className\":\"text-neutral-500\",\"children\":\"Insurance Claim Denial Management\"}]]}],[\"$\",\"p\",null,{\"className\":\"mb-3 text-xs font-medium uppercase tracking-widest text-neutral-400\",\"children\":\"Sub-research · February 2026\"}],[\"$\",\"article\",null,{\"className\":\"prose-report markdown-report\",\"children\":[[\"$\",\"h1\",\"h1-0\",{\"className\":\"text-3xl font-semibold leading-tight tracking-tight text-neutral-900 sm:text-4xl mt-0 mb-4\",\"children\":\"Insurance Claim Denial Management\"}],\"\\n\",[\"$\",\"p\",\"p-0\",{\"className\":\"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Prepared:\"}],\" 2026-02-24\\n\",[\"$\",\"strong\",\"strong-1\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Data vintage:\"}],\" Primarily 2023-2025 sources (from analyst training data; live web verification was unavailable)\\n\",[\"$\",\"strong\",\"strong-2\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Caveat:\"}],\" WebSearch and WebFetch tools were blocked during this session. All figures below are drawn from the analyst's training corpus (cut-off May 2025) and cite the original publication sources. Numbers should be independently verified before use in investment memos.\"]}],\"\\n\",[\"$\",\"hr\",\"hr-0\",{\"className\":\"my-8 border-neutral-100\"}],\"\\n\",[\"$\",\"h2\",\"h2-0\",{\"className\":\"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28\",\"children\":\"1. PROBLEM MARKET SIZE\"}],\"\\n\",[\"$\",\"h3\",\"h3-0\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"Revenue at Risk from Claim Denials\"}],\"\\n\",[\"$\",\"div\",\"table-0\",{\"className\":\"my-6 overflow-x-auto rounded-lg border border-neutral-200\",\"children\":[\"$\",\"table\",null,{\"className\":\"w-full text-sm\",\"children\":[[\"$\",\"thead\",\"thead-0\",{\"className\":\"border-b border-neutral-200 bg-neutral-50\",\"children\":[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"th\",\"th-0\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Metric\"}],[\"$\",\"th\",\"th-1\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Value\"}],[\"$\",\"th\",\"th-2\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Source\"}]]}]}],[\"$\",\"tbody\",\"tbody-0\",{\"className\":\"divide-y divide-neutral-100\",\"children\":[[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Total US hospital revenue billed to insurers (2024)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~$1.5 trillion\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"AHA Annual Survey / CMS NHE data\"}]]}],[\"$\",\"tr\",\"tr-1\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Initial denial rate (industry average)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"10-15% of all claims; up to 20-25% at some systems\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"HFMA 2023 \\\"Denial Benchmarking\\\" report; Experian Health 2024 survey\"}]]}],[\"$\",\"tr\",\"tr-2\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Revenue initially denied\"}],\"$Lf\",\"$L10\"]}],\"$L11\",\"$L12\"]}]]}]}],\"\\n\",\"$L13\",\"\\n\",\"$L14\",\"\\n\",\"$L15\",\"\\n\",\"$L16\",\"\\n\",\"$L17\",\"\\n\",\"$L18\",\"\\n\",\"$L19\",\"\\n\",\"$L1a\",\"\\n\",\"$L1b\",\"\\n\",\"$L1c\",\"\\n\",\"$L1d\",\"\\n\",\"$L1e\",\"\\n\",\"$L1f\",\"\\n\",\"$L20\",\"\\n\",\"$L21\",\"\\n\",\"$L22\",\"\\n\",\"$L23\",\"\\n\",\"$L24\",\"\\n\",\"$L25\",\"\\n\",\"$L26\",\"\\n\",\"$L27\",\"\\n\",\"$L28\",\"\\n\",\"$L29\",\"\\n\",\"$L2a\",\"\\n\",\"$L2b\",\"\\n\",\"$L2c\",\"\\n\",\"$L2d\",\"\\n\",\"$L2e\",\"\\n\",\"$L2f\",\"\\n\",\"$L30\",\"\\n\",\"$L31\",\"\\n\",\"$L32\",\"\\n\",\"$L33\",\"\\n\",\"$L34\",\"\\n\",\"$L35\",\"\\n\",\"$L36\",\"\\n\",\"$L37\",\"\\n\",\"$L38\",\"\\n\",\"$L39\",\"\\n\",\"$L3a\",\"\\n\",\"$L3b\",\"\\n\",\"$L3c\",\"\\n\",\"$L3d\",\"\\n\",\"$L3e\",\"\\n\",\"$L3f\",\"\\n\",\"$L40\",\"\\n\",\"$L41\",\"\\n\",\"$L42\",\"\\n\",\"$L43\",\"\\n\",\"$L44\",\"\\n\",\"$L45\",\"\\n\",\"$L46\",\"\\n\",\"$L47\",\"\\n\",\"$L48\",\"\\n\",\"$L49\",\"\\n\",\"$L4a\",\"\\n\",\"$L4b\",\"\\n\",\"$L4c\",\"\\n\",\"$L4d\",\"\\n\",\"$L4e\",\"\\n\",\"$L4f\",\"\\n\",\"$L50\",\"\\n\",\"$L51\",\"\\n\",\"$L52\",\"\\n\",\"$L53\",\"\\n\",\"$L54\",\"\\n\",\"$L55\",\"\\n\",\"$L56\",\"\\n\",\"$L57\"]}],\"$L58\"]}]}]\n"])</script><script>self.__next_f.push([1,"f:[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"$$150B - $225B annually\"}]}]\n10:[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Derived from above\"}]\n11:[\"$\",\"tr\",\"tr-3\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Net write-off from denials (after appeals)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~1.5-3% of net patient revenue\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"HFMA; Crowe RCA benchmarking\"}]]}]\n12:[\"$\",\"tr\",\"tr-4\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Estimated annual write-offs from denials\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"$$20B - $45B\"}]}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Derived; aligns with KFF and Advisory Board estimates\"}]]}]\n13:[\"$\",\"h3\",\"h3-1\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"Cost Hospitals Spend on Denial Management\"}]\n"])</script><script>self.__next_f.push([1,"14:[\"$\",\"div\",\"table-1\",{\"className\":\"my-6 overflow-x-auto rounded-lg border border-neutral-200\",\"children\":[\"$\",\"table\",null,{\"className\":\"w-full text-sm\",\"children\":[[\"$\",\"thead\",\"thead-0\",{\"className\":\"border-b border-neutral-200 bg-neutral-50\",\"children\":[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"th\",\"th-0\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Metric\"}],[\"$\",\"th\",\"th-1\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Value\"}],[\"$\",\"th\",\"th-2\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Source\"}]]}]}],[\"$\",\"tbody\",\"tbody-0\",{\"className\":\"divide-y divide-neutral-100\",\"children\":[[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Average cost to rework/appeal a single denied claim\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$25 - $118 per claim (varies by complexity)\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"AAPC 2023; Change Healthcare 2024 Revenue Cycle Index\"}]]}],[\"$\",\"tr\",\"tr-1\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Estimated total industry spend on denial management (staff, appeals, outsourcing, write-offs combined)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"$$19.7B - $25B+\"}]}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Becker's Hospital Review 2023; derived from FTE and outsourcing data\"}]]}],[\"$\",\"tr\",\"tr-2\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Average hospital employs dedicated denial FTEs\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"15-50 FTEs per mid-large hospital system\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"HFMA workforce surveys\"}]]}],[\"$\",\"tr\",\"tr-3\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Avg fully loaded cost per denial management FTE\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$55,000 - $75,000/year\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Bureau of Labor Statistics; Becker's\"}]]}]]}]]}]}]\n"])</script><script>self.__next_f.push([1,"15:[\"$\",\"p\",\"p-1\",{\"className\":\"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Bottom line:\"}],\" Denials put $150B-225B of hospital revenue at risk annually. Hospitals collectively spend $20B+ fighting them, and still write off $20B-45B.\"]}]\n16:[\"$\",\"hr\",\"hr-1\",{\"className\":\"my-8 border-neutral-100\"}]\n17:[\"$\",\"h2\",\"h2-1\",{\"className\":\"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28\",\"children\":\"2. CURRENT SPEND TO MANAGE\"}]\n18:[\"$\",\"h3\",\"h3-2\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"Revenue Cycle Management (RCM) Software Market\"}]\n"])</script><script>self.__next_f.push([1,"19:[\"$\",\"div\",\"table-2\",{\"className\":\"my-6 overflow-x-auto rounded-lg border border-neutral-200\",\"children\":[\"$\",\"table\",null,{\"className\":\"w-full text-sm\",\"children\":[[\"$\",\"thead\",\"thead-0\",{\"className\":\"border-b border-neutral-200 bg-neutral-50\",\"children\":[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"th\",\"th-0\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Metric\"}],[\"$\",\"th\",\"th-1\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Value\"}],[\"$\",\"th\",\"th-2\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Source\"}]]}]}],[\"$\",\"tbody\",\"tbody-0\",{\"className\":\"divide-y divide-neutral-100\",\"children\":[[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2023 market size\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$154B - $160B (includes services + software)\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Grand View Research 2024; Verified Market Research\"}]]}],[\"$\",\"tr\",\"tr-1\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2024 estimated\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~$176B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Grand View Research\"}]]}],[\"$\",\"tr\",\"tr-2\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2030 forecast\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$329B - $398B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Grand View Research; Fortune Business Insights\"}]]}],[\"$\",\"tr\",\"tr-3\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"CAGR (2024-2030)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"10.3% - 11.5%\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Multiple analyst firms\"}]]}]]}]]}]}]\n"])</script><script>self.__next_f.push([1,"1a:[\"$\",\"p\",\"p-2\",{\"className\":\"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4\",\"children\":[\"$\",\"em\",\"em-0\",{\"children\":\"Note: The broader RCM market includes outsourced services, not just software. The software-only segment is a subset (~$20-25B in 2024).\"}]}]\n1b:[\"$\",\"h3\",\"h3-3\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"Denial Management Software (Sub-Segment)\"}]\n"])</script><script>self.__next_f.push([1,"1c:[\"$\",\"div\",\"table-3\",{\"className\":\"my-6 overflow-x-auto rounded-lg border border-neutral-200\",\"children\":[\"$\",\"table\",null,{\"className\":\"w-full text-sm\",\"children\":[[\"$\",\"thead\",\"thead-0\",{\"className\":\"border-b border-neutral-200 bg-neutral-50\",\"children\":[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"th\",\"th-0\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Metric\"}],[\"$\",\"th\",\"th-1\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Value\"}],[\"$\",\"th\",\"th-2\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Source\"}]]}]}],[\"$\",\"tbody\",\"tbody-0\",{\"className\":\"divide-y divide-neutral-100\",\"children\":[[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2023 estimated market size\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$4.5B - $5.5B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Derived from Grand View Research RCM segmentation\"}]]}],[\"$\",\"tr\",\"tr-1\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"CAGR\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"12-14%\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Market Research Future; Allied Market Research\"}]]}],[\"$\",\"tr\",\"tr-2\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2030 forecast\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$10B - $13B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Projected\"}]]}]]}]]}]}]\n"])</script><script>self.__next_f.push([1,"1d:[\"$\",\"h3\",\"h3-4\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"Medical Billing Outsourcing Market\"}]\n"])</script><script>self.__next_f.push([1,"1e:[\"$\",\"div\",\"table-4\",{\"className\":\"my-6 overflow-x-auto rounded-lg border border-neutral-200\",\"children\":[\"$\",\"table\",null,{\"className\":\"w-full text-sm\",\"children\":[[\"$\",\"thead\",\"thead-0\",{\"className\":\"border-b border-neutral-200 bg-neutral-50\",\"children\":[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"th\",\"th-0\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Metric\"}],[\"$\",\"th\",\"th-1\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Value\"}],[\"$\",\"th\",\"th-2\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Source\"}]]}]}],[\"$\",\"tbody\",\"tbody-0\",{\"className\":\"divide-y divide-neutral-100\",\"children\":[[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2023 market size\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$13.5B - $14.8B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Polaris Market Research; Grand View Research\"}]]}],[\"$\",\"tr\",\"tr-1\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"CAGR (2024-2030)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"10.1% - 12.3%\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Multiple sources\"}]]}],[\"$\",\"tr\",\"tr-2\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2030 forecast\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$26B - $30B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Projected\"}]]}]]}]]}]}]\n"])</script><script>self.__next_f.push([1,"1f:[\"$\",\"hr\",\"hr-2\",{\"className\":\"my-8 border-neutral-100\"}]\n20:[\"$\",\"h2\",\"h2-2\",{\"className\":\"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28\",\"children\":\"3. COST OF INACTION\"}]\n"])</script><script>self.__next_f.push([1,"21:[\"$\",\"div\",\"table-5\",{\"className\":\"my-6 overflow-x-auto rounded-lg border border-neutral-200\",\"children\":[\"$\",\"table\",null,{\"className\":\"w-full text-sm\",\"children\":[[\"$\",\"thead\",\"thead-0\",{\"className\":\"border-b border-neutral-200 bg-neutral-50\",\"children\":[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"th\",\"th-0\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Metric\"}],[\"$\",\"th\",\"th-1\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Value\"}],[\"$\",\"th\",\"th-2\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Source\"}]]}]}],[\"$\",\"tbody\",\"tbody-0\",{\"className\":\"divide-y divide-neutral-100\",\"children\":[[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"% of denied claims never appealed\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"50-65%\"}]}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Premier Inc. 2023 analysis; Advisory Board 2024\"}]]}],[\"$\",\"tr\",\"tr-1\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Reason most not appealed\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Cost-to-appeal exceeds claim value, or staff bandwidth exhausted\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"HFMA\"}]]}],[\"$\",\"tr\",\"tr-2\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Average cost to work one denial\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$25 (simple) to $118 (complex/clinical)\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Change Healthcare 2024 Index; AAPC\"}]]}],[\"$\",\"tr\",\"tr-3\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Average cost to file a formal appeal\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$48 - $118 per claim\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"AAPC; Experian Health\"}]]}],[\"$\",\"tr\",\"tr-4\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Revenue lost from uncontested denials annually\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"$$10B - $27B\"}],\" (est. 50-65% of $20B-$45B write-off pool)\"]}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Derived\"}]]}],[\"$\",\"tr\",\"tr-5\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Appeal overturn/success rate (when pursued)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"50-70%\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"MGMA 2023; HFMA\"}]]}]]}]]}]}]\n"])</script><script>self.__next_f.push([1,"22:[\"$\",\"p\",\"p-3\",{\"className\":\"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Key insight:\"}],\" More than half of denied claims are never contested, yet when hospitals do appeal, they win 50-70% of the time. This represents a massive recoverable revenue pool that is abandoned due to operational capacity constraints.\"]}]\n23:[\"$\",\"hr\",\"hr-3\",{\"className\":\"my-8 border-neutral-100\"}]\n24:[\"$\",\"h2\",\"h2-3\",{\"className\":\"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28\",\"children\":\"4. VOLUME FREQUENCY\"}]\n"])</script><script>self.__next_f.push([1,"25:[\"$\",\"div\",\"table-6\",{\"className\":\"my-6 overflow-x-auto rounded-lg border border-neutral-200\",\"children\":[\"$\",\"table\",null,{\"className\":\"w-full text-sm\",\"children\":[[\"$\",\"thead\",\"thead-0\",{\"className\":\"border-b border-neutral-200 bg-neutral-50\",\"children\":[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"th\",\"th-0\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Metric\"}],[\"$\",\"th\",\"th-1\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Value\"}],[\"$\",\"th\",\"th-2\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Source\"}]]}]}],[\"$\",\"tbody\",\"tbody-0\",{\"className\":\"divide-y divide-neutral-100\",\"children\":[[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Total medical claims submitted/year (US, all payers)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"~6 billion\"}],\" claims (professional + institutional combined)\"]}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"CAQH 2024 Index; CMS data\"}]]}],[\"$\",\"tr\",\"tr-1\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Hospital/facility claims specifically\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~1.2 - 1.5 billion\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"AHA; derived from CMS\"}]]}],[\"$\",\"tr\",\"tr-2\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Initial denial rate (all claims)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"10-15%\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Experian Health 2024; Change Healthcare\"}]]}],[\"$\",\"tr\",\"tr-3\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Initial denial rate (hospital inpatient)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"15-25% (higher complexity)\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"HFMA 2023; KFF\"}]]}],[\"$\",\"tr\",\"tr-4\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Claims denied on first submission annually\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"~200-350 million\"}],\" hospital claims\"]}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Derived\"}]]}],[\"$\",\"tr\",\"tr-5\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Prior authorization denial rate (Medicare Advantage)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"13-18% of prior auth requests\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"KFF 2024 Medicare Advantage report; OIG\"}]]}],[\"$\",\"tr\",\"tr-6\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Appeals filed as % of denials\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"35-50%\"}]}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Premier; Advisory Board\"}]]}],[\"$\",\"tr\",\"tr-7\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Estimated appeals filed annually (hospital)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~70-175 million\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Derived\"}]]}],\"$L59\",\"$L5a\"]}]]}]}]\n"])</script><script>self.__next_f.push([1,"26:[\"$\",\"hr\",\"hr-4\",{\"className\":\"my-8 border-neutral-100\"}]\n27:[\"$\",\"h2\",\"h2-4\",{\"className\":\"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28\",\"children\":\"5. WHY STILL UNSOLVED\"}]\n28:[\"$\",\"p\",\"p-4\",{\"className\":\"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4\",\"children\":[\"Despite billions invested in RCM technology, denial rates have \",[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"risen ~23% over the past decade\"}],\" (Change Healthcare Index, 2024). Key structural reasons:\"]}]\n29:[\"$\",\"h3\",\"h3-5\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"5.1 Payer Algorithm Changes (Moving Target Problem)\"}]\n2a:[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":\"Insurers continuously update clinical criteria, coverage policies, and prior auth rules\"}],\"\\n\",[\"$\",\"li\",\"li-1\",{\"className\":\"leading-relaxed\",\"children\":\"Medicare Advantage plans use proprietary AI/ML algorithms to auto-adjudicate (and auto-deny) claims\"}],\"\\n\",[\"$\",\"li\",\"li-2\",{\"className\":\"leading-relaxed\",\"children\":\"OIG found MA plans denied 13-18% of prior auths, many of which met Medicare coverage criteria\"}],\"\\n\",[\"$\",\"li\",\"li-3\",{\"className\":\"leading-relaxed\",\"children\":\"Payer rule changes outpace provider RCM software update cycles\"}],\"\\n\"]}]\n2b:[\"$\",\"h3\",\"h3-6\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"5.2 Coding Complexity Explosion\"}]\n2c:[\"$\",\"ul\",\"ul-1\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":\"ICD-10 has ~72,000 diagnosis codes vs. ~14,000 in ICD-9\"}],\"\\n\",[\"$\",\"li\",\"li-1\",{\"className\":\"leading-relaxed\",\"children\":\"CPT code updates annually (300+ changes/year)\"}],\"\\n\",[\"$\",\"li\",\"li-2\",{\"className\":\"leading-relaxed\",\"children\":\"Modifier requirements increasingly complex\"}],\"\\n\",[\"$\",\"li\",\"li-3\",{\"className\":\"leading-relaxed\",\"children\":\"Clinical documentation must precisely match coding requirements\"}],\"\\n\"]}]\n2d:[\"$\",\"h3\",\"h3-7\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"5.3 Staff Turnover and Workforce Crisis\"}]\n2e:[\"$\",\"ul\",\"ul-2\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":\"Medical coder/biller turnover: 25-40% annually (AAPC 2024 salary survey)\"}],\"\\n\",[\"$\",\"li\",\"li-1\",{\"className\":\"leading-relaxed\",\"children\":\"Average time to train a denial management specialist: 6-12 months\"}],\"\\n\",[\"$\",\"li\",\"li-2\",{\"className\":\"leading-relaxed\",\"children\":\"Post-COVID burnout accelerated departures from revenue cycle roles\"}],\"\\n\",[\"$\",\"li\",\"li-3\",{\"className\":\"leading-relaxed\",\"children\":\"Experienced coders retiring faster than replacements entering\"}],\"\\n\"]}]\n2f:[\"$\",\"h3\",\"h3-8\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"5.4 Data Fragmentation\"}]\n30:[\"$\",\"ul\",\"ul-3\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":\"Average hospital uses 15+ disparate systems (EHR, PM, clearinghouse, payer portals)\"}],\"\\n\",[\"$\",\"li\",\"li-1\",{\"className\":\"leading-relaxed\",\"children\":\"Lack of real-time eligibility/benefit verification at point of care\"}],\"\\n\",[\"$\",\"li\",\"li-2\",{\"className\":\"leading-relaxed\",\"children\":\"Clinical documentation lives in EHR; billing data in PM system; payer rules on external portals\"}],\"\\n\",[\"$\",\"li\",\"li-3\",{\"className\":\"leading-relaxed\",\"children\":\"No single source of truth connecting clinical, financial, and payer data\"}],\"\\n\"]}]\n31:[\"$\",\"h3\",\"h3-9\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"5.5 Misaligned Incentives\"}]\n32:[\"$\",\"ul\",\"ul-4\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children"])</script><script>self.__next_f.push([1,"\":\"Payers benefit financially from denials (float, write-offs)\"}],\"\\n\",[\"$\",\"li\",\"li-1\",{\"className\":\"leading-relaxed\",\"children\":\"Payers face minimal penalties for inappropriate denials\"}],\"\\n\",[\"$\",\"li\",\"li-2\",{\"className\":\"leading-relaxed\",\"children\":\"Provider appeals process is deliberately cumbersome\"}],\"\\n\",[\"$\",\"li\",\"li-3\",{\"className\":\"leading-relaxed\",\"children\":\"CMS has been slow to enforce payer accountability\"}],\"\\n\"]}]\n33:[\"$\",\"h3\",\"h3-10\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"5.6 Legacy RCM Software Limitations\"}]\n34:[\"$\",\"ul\",\"ul-5\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":\"Most RCM platforms are rules-based, not predictive\"}],\"\\n\",[\"$\",\"li\",\"li-1\",{\"className\":\"leading-relaxed\",\"children\":\"Retrospective denial tracking vs. prospective denial prevention\"}],\"\\n\",[\"$\",\"li\",\"li-2\",{\"className\":\"leading-relaxed\",\"children\":\"Batch processing vs. real-time intervention\"}],\"\\n\",[\"$\",\"li\",\"li-3\",{\"className\":\"leading-relaxed\",\"children\":\"Limited NLP/AI capability for clinical documentation analysis\"}],\"\\n\"]}]\n35:[\"$\",\"hr\",\"hr-5\",{\"className\":\"my-8 border-neutral-100\"}]\n36:[\"$\",\"h2\",\"h2-5\",{\"className\":\"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28\",\"children\":\"6. WILLINGNESS TO PAY SIGNALS\"}]\n37:[\"$\",\"h3\",\"h3-11\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"What Hospitals Pay Today\"}]\n"])</script><script>self.__next_f.push([1,"38:[\"$\",\"div\",\"table-7\",{\"className\":\"my-6 overflow-x-auto rounded-lg border border-neutral-200\",\"children\":[\"$\",\"table\",null,{\"className\":\"w-full text-sm\",\"children\":[[\"$\",\"thead\",\"thead-0\",{\"className\":\"border-b border-neutral-200 bg-neutral-50\",\"children\":[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"th\",\"th-0\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Category\"}],[\"$\",\"th\",\"th-1\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Annual Spend\"}],[\"$\",\"th\",\"th-2\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Source\"}]]}]}],[\"$\",\"tbody\",\"tbody-0\",{\"className\":\"divide-y divide-neutral-100\",\"children\":[[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"In-house RCM team (avg mid-size hospital, ~50 FTEs)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$3M - $5M/year\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"BLS; HFMA\"}]]}],[\"$\",\"tr\",\"tr-1\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"In-house RCM team (large health system, 200+ FTEs)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$12M - $20M/year\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Becker's\"}]]}],[\"$\",\"tr\",\"tr-2\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Outsourced RCM services (% of collections model)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"4-8% of net patient revenue\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"HFMA; vendor benchmarks\"}]]}],[\"$\",\"tr\",\"tr-3\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Outsourced RCM for a $500M revenue hospital\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$20M - $40M/year\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Derived\"}]]}],[\"$\",\"tr\",\"tr-4\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Denial management software (per-provider pricing)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$50K - $500K/year per facility\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Vendor pricing; KLAS\"}]]}],[\"$\",\"tr\",\"tr-5\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"AI-powered denial prevention platforms\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$200K - $1M+/year per health system\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"KLAS 2024; vendor data\"}]]}]]}]]}]}]\n"])</script><script>self.__next_f.push([1,"39:[\"$\",\"h3\",\"h3-12\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"VC/PE Investment Activity (2023-2025)\"}]\n"])</script><script>self.__next_f.push([1,"3a:[\"$\",\"div\",\"table-8\",{\"className\":\"my-6 overflow-x-auto rounded-lg border border-neutral-200\",\"children\":[\"$\",\"table\",null,{\"className\":\"w-full text-sm\",\"children\":[[\"$\",\"thead\",\"thead-0\",{\"className\":\"border-b border-neutral-200 bg-neutral-50\",\"children\":[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"th\",\"th-0\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Company / Deal\"}],[\"$\",\"th\",\"th-1\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Amount\"}],[\"$\",\"th\",\"th-2\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Date\"}],[\"$\",\"th\",\"th-3\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Investor(s)\"}]]}]}],[\"$\",\"tbody\",\"tbody-0\",{\"className\":\"divide-y divide-neutral-100\",\"children\":[[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Waystar IPO\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~$968M raised (IPO)\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"June 2024\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Public markets (backed by EQT, CPPIB)\"}]]}],[\"$\",\"tr\",\"tr-1\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Akasa (AI for RCM)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$60M Series B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2023\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Andreessen Horowitz (a16z)\"}]]}],[\"$\",\"tr\",\"tr-2\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"AKASA total raised\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$120M+\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Through 2024\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"a16z, BOND, others\"}]]}],[\"$\",\"tr\",\"tr-3\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Olive AI (RCM automation)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Wound down; assets acquired by Waystar, others\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2023\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Previously raised $900M+\"}]]}],[\"$\",\"tr\",\"tr-4\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Infinx (AI prior auth)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$75M+ total\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2023-2024\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Multiple PE/VC\"}]]}],[\"$\",\"tr\",\"tr-5\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Apixio/ClaimLogiq (AI denials)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Acquired by New Mountain Capital\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2023\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"PE\"}]]}],[\"$\",\"tr\",\"tr-6\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"R1 RCM\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Acquired by TowerBrook/CD\u0026R for $8.9B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2024\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"PE\"}]]}],[\"$\",\"tr\",\"tr-7\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Ensemble Health Partners\"}],\"$L5b\",\"$L5c\",\"$L5d\"]}],\"$L5e\",\"$L5f\"]}]]}]}]\n"])</script><script>self.__next_f.push([1,"3b:[\"$\",\"p\",\"p-5\",{\"className\":\"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Signal strength:\"}],\" The R1 RCM acquisition at $8.9B and Waystar IPO at ~$3.7B market cap on listing day demonstrate massive PE/public market appetite. Multiple AI-native startups raising $50M-$120M rounds specifically for denial management signals strong WTP for next-gen solutions.\"]}]\n3c:[\"$\",\"hr\",\"hr-6\",{\"className\":\"my-8 border-neutral-100\"}]\n3d:[\"$\",\"h2\",\"h2-6\",{\"className\":\"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28\",\"children\":\"7. MARKET GROWTH RATE\"}]\n"])</script><script>self.__next_f.push([1,"3e:[\"$\",\"div\",\"table-9\",{\"className\":\"my-6 overflow-x-auto rounded-lg border border-neutral-200\",\"children\":[\"$\",\"table\",null,{\"className\":\"w-full text-sm\",\"children\":[[\"$\",\"thead\",\"thead-0\",{\"className\":\"border-b border-neutral-200 bg-neutral-50\",\"children\":[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"th\",\"th-0\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Segment\"}],[\"$\",\"th\",\"th-1\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"2024 Size (Est.)\"}],[\"$\",\"th\",\"th-2\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"2030 Forecast\"}],[\"$\",\"th\",\"th-3\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"CAGR\"}]]}]}],[\"$\",\"tbody\",\"tbody-0\",{\"className\":\"divide-y divide-neutral-100\",\"children\":[[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Total RCM Market (services + software)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$176B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$329B - $398B\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"10.3% - 11.5%\"}]]}],[\"$\",\"tr\",\"tr-1\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"RCM Software Only\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$20B - $25B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$48B - $55B\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"11% - 13%\"}]]}],[\"$\",\"tr\",\"tr-2\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Denial Management Software\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$5B - $6B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$10B - $13B\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"12% - 14%\"}]]}],[\"$\",\"tr\",\"tr-3\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Medical Billing Outsourcing\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$14B - $15B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$26B - $30B\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"10% - 12%\"}]]}],[\"$\",\"tr\",\"tr-4\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"AI in Healthcare RCM (sub-segment)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$2B - $3B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$8B - $12B\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"20% - 25%\"}]]}]]}]]}]}]\n"])</script><script>self.__next_f.push([1,"3f:[\"$\",\"p\",\"p-6\",{\"className\":\"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Key growth drivers:\"}]}]\n40:[\"$\",\"ul\",\"ul-6\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":\"Regulatory complexity increasing (No Surprises Act, prior auth reform)\"}],\"\\n\",[\"$\",\"li\",\"li-1\",{\"className\":\"leading-relaxed\",\"children\":\"Labor shortages forcing automation adoption\"}],\"\\n\",[\"$\",\"li\",\"li-2\",{\"className\":\"leading-relaxed\",\"children\":\"Medicare Advantage enrollment growth (more complex payer mix)\"}],\"\\n\",[\"$\",\"li\",\"li-3\",{\"className\":\"leading-relaxed\",\"children\":\"AI/ML maturation enabling predictive denial prevention\"}],\"\\n\",[\"$\",\"li\",\"li-4\",{\"className\":\"leading-relaxed\",\"children\":\"CMS interoperability mandates creating data availability\"}],\"\\n\"]}]\n41:[\"$\",\"hr\",\"hr-7\",{\"className\":\"my-8 border-neutral-100\"}]\n42:[\"$\",\"h2\",\"h2-7\",{\"className\":\"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28\",\"children\":\"8. KEY PLAYERS TODAY\"}]\n43:[\"$\",\"h3\",\"h3-13\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"Major RCM / Denial Management Companies\"}]\n"])</script><script>self.__next_f.push([1,"44:[\"$\",\"div\",\"table-10\",{\"className\":\"my-6 overflow-x-auto rounded-lg border border-neutral-200\",\"children\":[\"$\",\"table\",null,{\"className\":\"w-full text-sm\",\"children\":[[\"$\",\"thead\",\"thead-0\",{\"className\":\"border-b border-neutral-200 bg-neutral-50\",\"children\":[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"th\",\"th-0\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Company\"}],[\"$\",\"th\",\"th-1\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Est. Revenue (2024)\"}],[\"$\",\"th\",\"th-2\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Segment Focus\"}],[\"$\",\"th\",\"th-3\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Notes\"}]]}]}],[\"$\",\"tbody\",\"tbody-0\",{\"className\":\"divide-y divide-neutral-100\",\"children\":[[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Waystar\"}]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~$770M-$850M\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"RCM software, clearinghouse, denial mgmt\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"IPO June 2024; EQT-backed; acquired Olive AI assets\"}]]}],[\"$\",\"tr\",\"tr-1\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"R1 RCM\"}]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~$2.2B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"End-to-end RCM outsourcing + tech\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Acquired by TowerBrook/CD\u0026R for $8.9B (2024)\"}]]}],[\"$\",\"tr\",\"tr-2\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Cotiviti\"}],\" (Verscend)\"]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~$1.0B-$1.2B\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Payment accuracy, analytics, risk adjustment\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Owned by Veritas Capital; serves payer + provider\"}]]}],[\"$\",\"tr\",\"tr-3\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Change Healthcare\"}],\" (Optum)\"]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~$3.5B+ (segment)\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Clearinghouse, RCM, payment integrity\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Part of UnitedHealth/Optum after $7.8B acquisition (2022); major cyberattack Feb 2024\"}]]}],[\"$\",\"tr\",\"tr-4\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"nThrive\"}],\" (now part of R1 RCM)\"]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Folded into R1\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Coding, CDI, denial management\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Merged with R1 RCM\"}]]}],[\"$\",\"tr\",\"tr-5\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Omega Healthcare\"}]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~$500M-$700M\"}],\"$L60\",\"$L61\"]}],\"$L62\",\"$L63\",\"$L64\",\"$L65\"]}]]}]}]\n"])</script><script>self.__next_f.push([1,"45:[\"$\",\"h3\",\"h3-14\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"AI-Native Disruptors\"}]\n"])</script><script>self.__next_f.push([1,"46:[\"$\",\"div\",\"table-11\",{\"className\":\"my-6 overflow-x-auto rounded-lg border border-neutral-200\",\"children\":[\"$\",\"table\",null,{\"className\":\"w-full text-sm\",\"children\":[[\"$\",\"thead\",\"thead-0\",{\"className\":\"border-b border-neutral-200 bg-neutral-50\",\"children\":[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"th\",\"th-0\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Company\"}],[\"$\",\"th\",\"th-1\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Funding / Stage\"}],[\"$\",\"th\",\"th-2\",{\"className\":\"px-4 py-3 text-left font-medium text-neutral-700\",\"children\":\"Focus\"}]]}]}],[\"$\",\"tbody\",\"tbody-0\",{\"className\":\"divide-y divide-neutral-100\",\"children\":[[\"$\",\"tr\",\"tr-0\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"AKASA\"}]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$120M+ raised\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"AI-powered RCM automation\"}]]}],[\"$\",\"tr\",\"tr-1\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Infinx\"}]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$75M+ raised\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"AI prior authorization\"}]]}],[\"$\",\"tr\",\"tr-2\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Apixio / ClaimLogiq\"}]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"PE-backed (New Mountain)\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"AI-powered denial management\"}]]}],[\"$\",\"tr\",\"tr-3\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Adonis\"}]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~$20M+ raised\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"AI denial prevention for physician groups\"}]]}],[\"$\",\"tr\",\"tr-4\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Rhyme Health\"}]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Early stage\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"AI denial appeals automation\"}]]}],[\"$\",\"tr\",\"tr-5\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Valer\"}]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Early stage\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Denial prediction and prevention\"}]]}]]}]]}]}]\n"])</script><script>self.__next_f.push([1,"47:[\"$\",\"hr\",\"hr-8\",{\"className\":\"my-8 border-neutral-100\"}]\n48:[\"$\",\"h2\",\"h2-8\",{\"className\":\"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28\",\"children\":\"9. KEY SOURCES\"}]\n49:[\"$\",\"p\",\"p-7\",{\"className\":\"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4\",\"children\":\"All sources referenced in this report. Note: URLs are provided as best-known links; some may require subscription access.\"}]\n4a:[\"$\",\"h3\",\"h3-15\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"Industry Associations and Government\"}]\n"])</script><script>self.__next_f.push([1,"4b:[\"$\",\"ol\",\"ol-0\",{\"className\":\"list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"HFMA (Healthcare Financial Management Association)\"}],\" - Denial benchmarking reports and workforce surveys\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.hfma.org/topics/financial-sustainability/\",\"children\":\"https://www.hfma.org/topics/financial-sustainability/\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-1\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"KFF (Kaiser Family Foundation)\"}],\" - Medicare Advantage denial data\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.kff.org/medicare/issue-brief/over-35-million-prior-authorization-requests-were-submitted-to-medicare-advantage-plans-in-2021/\",\"children\":\"https://www.kff.org/medicare/issue-brief/over-35-million-prior-authorization-requests-were-submitted-to-medicare-advantage-plans-in-2021/\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-2\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"CMS National Health Expenditure Data\"}],\" - Total healthcare spending\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data\",\"children\":\"https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-3\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"OIG (HHS Office of Inspector General)\"}],\" - MA denial investigations\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://oig.hhs.gov/reports/\",\"children\":\"https://oig.hhs.gov/reports/\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-4\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"AHA (American Hospital Association)\"}],\" - Hospital statistics\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.aha.org/statistics\",\"children\":\"https://www.aha.org/statistics\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-5\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"CAQH Index\"}],\" - Claims volume and automation data\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.caqh.org/explorations/caqh-index\",\"children\":\"https://www.caqh.org/explorations/caqh-index\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\"]}]\n"])</script><script>self.__next_f.push([1,"4c:[\"$\",\"h3\",\"h3-16\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"Market Research Firms\"}]\n"])</script><script>self.__next_f.push([1,"4d:[\"$\",\"ol\",\"ol-1\",{\"className\":\"list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Grand View Research\"}],\" - RCM market analysis\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.grandviewresearch.com/industry-analysis/revenue-cycle-management-market\",\"children\":\"https://www.grandviewresearch.com/industry-analysis/revenue-cycle-management-market\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-1\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Fortune Business Insights\"}],\" - RCM market forecast\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.fortunebusinessinsights.com/revenue-cycle-management-market-103045\",\"children\":\"https://www.fortunebusinessinsights.com/revenue-cycle-management-market-103045\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-2\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Polaris Market Research\"}],\" - Medical billing outsourcing\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.polarismarketresearch.com/industry-analysis/medical-billing-outsourcing-market\",\"children\":\"https://www.polarismarketresearch.com/industry-analysis/medical-billing-outsourcing-market\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-3\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Allied Market Research\"}],\" - Denial management market\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.alliedmarketresearch.com/\",\"children\":\"https://www.alliedmarketresearch.com/\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-4\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Market Research Future\"}],\" - Healthcare RCM\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.marketresearchfuture.com/\",\"children\":\"https://www.marketresearchfuture.com/\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\"]}]\n"])</script><script>self.__next_f.push([1,"4e:[\"$\",\"h3\",\"h3-17\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"Industry Publications and Data\"}]\n"])</script><script>self.__next_f.push([1,"4f:[\"$\",\"ol\",\"ol-2\",{\"className\":\"list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Change Healthcare / Optum Revenue Cycle Index\"}],\" - Denial rate trends and cost-to-appeal data\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.changehealthcare.com/insights/revenue-cycle-denials-index\",\"children\":\"https://www.changehealthcare.com/insights/revenue-cycle-denials-index\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-1\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Experian Health\"}],\" - State of Claims survey (2024)\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.experian.com/healthcare/\",\"children\":\"https://www.experian.com/healthcare/\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-2\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Becker's Hospital Review\"}],\" - RCM workforce and spending\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.beckershospitalreview.com/finance/\",\"children\":\"https://www.beckershospitalreview.com/finance/\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-3\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Fierce Healthcare\"}],\" - Denial rate trends\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.fiercehealthcare.com/finance\",\"children\":\"https://www.fiercehealthcare.com/finance\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-4\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"KLAS Research\"}],\" - RCM software vendor ratings\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://klasresearch.com/\",\"children\":\"https://klasresearch.com/\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-5\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Advisory Board (Optum)\"}],\" - Denial management analytics\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.advisory.com/topics/revenue-cycle-management\",\"children\":\"https://www.advisory.com/topics/revenue-cycle-management\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-6\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Premier Inc.\"}],\" - Denial analytics and benchmarking\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.premierinc.com/\",\"children\":\"https://www.premierinc.com/\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-7\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"AAPC\"}],\" - Coding workforce and salary data\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",\"$L66\",\"\\n\"]}],\"\\n\"]}],\"\\n\",\"$L67\",\"\\n\"]}]\n"])</script><script>self.__next_f.push([1,"50:[\"$\",\"h3\",\"h3-18\",{\"className\":\"text-base font-medium text-neutral-800 mt-10 mb-3\",\"children\":\"Deal / Investment Sources\"}]\n"])</script><script>self.__next_f.push([1,"51:[\"$\",\"ol\",\"ol-3\",{\"className\":\"list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Waystar S-1 / IPO Filing\"}],\" - SEC Edgar\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany\u0026company=waystar\",\"children\":\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany\u0026company=waystar\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-1\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"R1 RCM Take-Private\"}],\" - Press coverage\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.beckershospitalreview.com/finance/r1-rcm-acquired-for-8-9b.html\",\"children\":\"https://www.beckershospitalreview.com/finance/r1-rcm-acquired-for-8-9b.html\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\",[\"$\",\"li\",\"li-2\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"AKASA Funding\"}],\" - Crunchbase / press releases\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.akasa.com/\",\"children\":\"https://www.akasa.com/\"}]}],\"\\n\"]}],\"\\n\"]}],\"\\n\"]}]\n"])</script><script>self.__next_f.push([1,"52:[\"$\",\"hr\",\"hr-9\",{\"className\":\"my-8 border-neutral-100\"}]\n53:[\"$\",\"h2\",\"h2-9\",{\"className\":\"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28\",\"children\":\"EXECUTIVE SUMMARY\"}]\n54:[\"$\",\"p\",\"p-8\",{\"className\":\"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4\",\"children\":\"The US insurance claim denial management problem represents one of the largest inefficiencies in healthcare:\"}]\n"])</script><script>self.__next_f.push([1,"55:[\"$\",\"ul\",\"ul-7\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"$$150B-$225B\"}],\" in hospital revenue is initially denied annually\"]}],\"\\n\",[\"$\",\"li\",\"li-1\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"$$20B-$45B\"}],\" is permanently written off, with \",[\"$\",\"strong\",\"strong-1\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"50-65% of denials never even appealed\"}]]}],\"\\n\",[\"$\",\"li\",\"li-2\",{\"className\":\"leading-relaxed\",\"children\":[\"When hospitals do appeal, they win \",[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"50-70% of the time\"}],\" -- revealing a massive recoverable revenue pool abandoned due to operational constraints\"]}],\"\\n\",[\"$\",\"li\",\"li-3\",{\"className\":\"leading-relaxed\",\"children\":[\"Hospitals spend \",[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"$$20B+ annually\"}],\" on denial management through a combination of in-house staff, outsourced services, and technology\"]}],\"\\n\",[\"$\",\"li\",\"li-4\",{\"className\":\"leading-relaxed\",\"children\":[\"The RCM market is growing at \",[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"10-13% CAGR\"}],\" with AI-specific sub-segments growing at \",[\"$\",\"strong\",\"strong-1\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"20-25%\"}]]}],\"\\n\",[\"$\",\"li\",\"li-5\",{\"className\":\"leading-relaxed\",\"children\":[\"PE/VC conviction is high: \",[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"R1 RCM acquired for $8.9B\"}],\", \",[\"$\",\"strong\",\"strong-1\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Waystar IPO at ~$3.7B\"}],\", and \",[\"$\",\"strong\",\"strong-2\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"$$200M+ deployed into AI-native denial management startups\"}],\" in 2023-2024\"]}],\"\\n\"]}]\n"])</script><script>self.__next_f.push([1,"56:[\"$\",\"p\",\"p-9\",{\"className\":\"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4\",\"children\":\"The problem persists because it is structurally adversarial (payers benefit from denials), operationally complex (72,000 ICD-10 codes, constantly changing payer rules), and plagued by workforce challenges (25-40% coder turnover). Legacy RCM tools are rules-based and retrospective. The market is ripe for AI-native solutions that can predict denials before submission, auto-generate appeals, and adapt in real-time to payer algorithm changes.\"}]\n57:[\"$\",\"p\",\"p-10\",{\"className\":\"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Largest opportunity vector:\"}],\" Converting the 50-65% of denials that are currently abandoned into appealed and recovered revenue using AI-powered automation. At a 60% appeal success rate, this represents \",[\"$\",\"strong\",\"strong-1\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"$$6B-$16B in recoverable revenue annually\"}],\" -- a value proposition that can support premium SaaS pricing.\"]}]\n58:[\"$\",\"div\",null,{\"className\":\"mt-16 flex flex-wrap items-center gap-4 border-t border-neutral-100 pt-8\",\"children\":[[\"$\",\"$Le\",null,{\"href\":\"/reports/market-opportunity-research\",\"className\":\"inline-flex items-center gap-1.5 text-sm text-neutral-500 hover:text-neutral-900 transition-colors group\",\"children\":[[\"$\",\"span\",null,{\"className\":\"transition-transform group-hover:-translate-x-0.5\",\"children\":\"←\"}],\"Back to AI Market Opportunity Research\"]}],[\"$\",\"span\",null,{\"className\":\"text-neutral-300\",\"children\":\"·\"}],[\"$\",\"$Le\",null,{\"href\":\"/research\",\"className\":\"inline-flex items-center gap-1.5 text-sm text-neutral-500 hover:text-neutral-900 transition-colors group\",\"children\":[[\"$\",\"span\",null,{\"className\":\"transition-transform group-hover:-translate-x-0.5\",\"children\":\"←\"}],\"Back to Research\"]}]]}]\n"])</script><script>self.__next_f.push([1,"59:[\"$\",\"tr\",\"tr-8\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Average time to resolve a denial (rework + appeal)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"30-60 days\"}],\" (simple); \",[\"$\",\"strong\",\"strong-1\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"90-180+ days\"}],\" (complex/multi-level appeal)\"]}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"HFMA; Waystar benchmarking data\"}]]}]\n5a:[\"$\",\"tr\",\"tr-9\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Average days in A/R for denied claims\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"45-90 days beyond initial billing cycle\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"MGMA benchmarks\"}]]}]\n5b:[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Acquired by Bon Secours for strategic partnership\"}]\n5c:[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2024\"}]\n5d:[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Health system\"}]\n5e:[\"$\",\"tr\",\"tr-8\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Nividous / Autonomize AI\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$15-30M rounds for RCM AI startups\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2023-2024\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Various VC\"}]]}]\n5f:[\"$\",\"tr\",\"tr-9\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Medallion (credentialing/RCM adjacent)\"}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"$$44M Series C\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"2024\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Various\"}]]}]\n60:[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"RCM outsourcing (India-based operations)\"}]\n61:[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Large offshore BPO for RCM\"}]\n62:[\"$\",\"tr\",\"tr-6\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Ensemble Health Partners\"}]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~$1.0B+\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"End-to-end RCM outsourcing\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Strategic deals with health systems\"}]]}]\n63:[\"$\",\"tr\",\"tr-7\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"GeBBS Healthcare\"}]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~$200M-$300M\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"RCM outsourcing, coding\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"India-based\"}]]}]\n64:[\"$\",\"tr\",\"tr-8\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"AGS Health\"}]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~$150M-$250M\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"RCM outsour"])</script><script>self.__next_f.push([1,"cing, denial management\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"India-based\"}]]}]\n65:[\"$\",\"tr\",\"tr-9\",{\"className\":\"bg-white\",\"children\":[[\"$\",\"td\",\"td-0\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"Experian Health\"}]}],[\"$\",\"td\",\"td-1\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"~$500M-$700M (health segment)\"}],[\"$\",\"td\",\"td-2\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Eligibility, claims, patient access\"}],[\"$\",\"td\",\"td-3\",{\"className\":\"px-4 py-3 text-neutral-600 align-top\",\"children\":\"Part of Experian plc\"}]]}]\n66:[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.aapc.com/\",\"children\":\"https://www.aapc.com/\"}]}]\n67:[\"$\",\"li\",\"li-8\",{\"className\":\"leading-relaxed\",\"children\":[[\"$\",\"strong\",\"strong-0\",{\"className\":\"font-semibold text-neutral-800\",\"children\":\"MGMA\"}],\" - Practice management benchmarks\",\"\\n\",[\"$\",\"ul\",\"ul-0\",{\"className\":\"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4\",\"children\":[\"\\n\",[\"$\",\"li\",\"li-0\",{\"className\":\"leading-relaxed\",\"children\":[\"$\",\"a\",\"a-0\",{\"href\":\"https://www.mgma.com/\",\"children\":\"https://www.mgma.com/\"}]}],\"\\n\"]}],\"\\n\"]}]\n"])</script><script>self.__next_f.push([1,"a:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1\"}]]\n"])</script><script>self.__next_f.push([1,"68:I[27201,[\"/rigidbodydynamicsai/_next/static/chunks/ff1a16fafef87110.js\",\"/rigidbodydynamicsai/_next/static/chunks/d2be314c3ece3fbe.js\"],\"IconMark\"]\n8:null\nc:[[\"$\",\"title\",\"0\",{\"children\":\"Insurance Claim Denial Management — AI Market Opportunity Research\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"15–25% of hospital claims are denied; $262B initially denied and $38–65B ultimately lost yearly. Denial management costs hospitals ~$19.7B; RCM market is $155–165B.\"}],[\"$\",\"meta\",\"2\",{\"property\":\"og:title\",\"content\":\"Rigid Body Dynamics AI — AI That Does the Work for You\"}],[\"$\",\"meta\",\"3\",{\"property\":\"og:description\",\"content\":\"We research what's next in AI and make it accessible — one problem at a time.\"}],[\"$\",\"meta\",\"4\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"5\",{\"name\":\"twitter:title\",\"content\":\"Rigid Body Dynamics AI — AI That Does the Work for You\"}],[\"$\",\"meta\",\"6\",{\"name\":\"twitter:description\",\"content\":\"We research what's next in AI and make it accessible — one problem at a time.\"}],[\"$\",\"link\",\"7\",{\"rel\":\"icon\",\"href\":\"/rigidbodydynamicsai/favicon.ico?favicon.0b3bf435.ico\",\"sizes\":\"256x256\",\"type\":\"image/x-icon\"}],[\"$\",\"link\",\"8\",{\"rel\":\"icon\",\"href\":\"/icon?64afa28a3da3d704\",\"alt\":\"$undefined\",\"type\":\"image/png\",\"sizes\":\"32x32\"}],[\"$\",\"$L68\",\"9\",{}]]\n"])</script></body></html>